164 results on '"Fei, Xiaochun"'
Search Results
2. Time interval between breast cancer diagnosis and surgery is associated with disease outcome
3. Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients
4. Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p
5. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
6. Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin.
7. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis
8. NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition
9. Can breast cancer patients with HER2 dual-equivocal tumours be managed as HER2-negative disease?
10. Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample
11. Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis
12. Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short‐term recurrence of hepatocellular carcinoma post‐radical surgery.
13. Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease.
14. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells
15. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p
16. Correction: Corrigendum: The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing
17. Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies: a single-institution study of 225 cases
18. Regulator of G-protein signaling 3 targeted by miR-126 correlates with poor prognosis in gastric cancer patients
19. EP3 receptor deficiency attenuates pulmonary hypertension through suppression of RHO/TGF-β1 signaling
20. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines
21. PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients
22. HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients.
23. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription.
24. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8
25. Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer.
26. A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab
27. CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer
28. Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis.
29. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
30. Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment.
31. Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases.
32. Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial‐mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4.
33. A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
34. Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients.
35. Application of Contrast‐Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
36. 21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes.
37. Clear cell changes in mucinous tubular and spindle cell carcinoma: cytoplasmic pallor/clearing within tubules, vacuoles or hybrid conventional clear cell carcinoma of kidney?
38. Letter to the editor on “Vasovagal reflex emergency caused by Riedel's thyroiditis: A case report and review of the literature”. Lymphocytic thyroiditis with multifocal non-tumor-associated psammoma bodies
39. SLC7A5 Functions as a Downstream Target Modulated by CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells.
40. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
41. MRI features of breast lymphoma: preliminary experience in seven cases.
42. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
43. Rare Ileal Ewing Sarcoma/Primitive Neuroectodermal Tumor on 18F-FDG PET/CT.
44. Corrigendum: Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
45. Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer.
46. Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study.
47. A Rim-Enhanced Mass with Central Cystic Changes on MR Imaging: How to Distinguish Breast Cancer from Inflammatory Breast Diseases?
48. Corrigendum: The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.
49. The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.
50. NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.